logo

For the Inventor, By the Inventor

Barcelona, Spain

Lluis Anglada

This inventor holds 5 USPTO granted patents. Top assignee: Ferrer Internacional, S.a.. Active years: 1998-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lluis Anglada. Retrieved from https://idiyas.com/inventor/lluis-anglada

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5

% Patents Active = 80.0

Average Co-Inventor Count = 5.4

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:

goldMedal5 out of 48 
 
Ferrer Internacional, S.a.
 patents

Years Active: 1998-2008

Loading Chart...
5 patents (USPTO):Explore Patents
1. 7323433 - R-(-)-1-[2-(7-chlorobenzo[b]thiopen-3-yl-methoxy)-2-(2,4-dichlorophenyl)-ethyl]-1H-imidazole (2008-01-29),
2. 6005115 - Forms A and B of (1999-12-21),
3. 5939555 - Polymorphs B and C of (1999-08-17),
4. 5798361 - 5H-thiazolo�3,2-a!pyrimidin-5-one derivatives (1998-08-25),
5. 5736558 - 4-(6-fluoro-1,2-benzisoxazolyl)-1 (1998-04-07),

Title: Biography of Lluis Anglada

Introduction

Lluis Anglada is a prominent inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating fungal infections and crop diseases. With a total of five patents to his name, Anglada's work has had a notable impact on both human and veterinary medicine.

Latest Patents

One of his latest patents is R-(-)-1-[2-(7-chlorobenzo[b]thiophen-3-yl-methoxy)-2-(2,4-dichlorophenyl)-ethyl]-1H-imidazole. This invention relates to the compound and its salts, as well as compositions for treating fungal infections in humans and animals, and combating crop diseases. The patent also describes a process for the preparation of these compounds.

Career Highlights

Anglada is associated with Ferrer Internacional, S.A., a company known for its innovative approaches in the pharmaceutical industry. His work at Ferrer has allowed him to explore various avenues in drug development and contribute to advancements in medical treatments.

Collaborations

Throughout his career, Anglada has collaborated with notable colleagues, including Rafael Foguet and Jose A Ortiz. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Lluis Anglada's contributions to the field of pharmaceuticals

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…